Afuco™ Anti-Human UPK1B ADCC Therapeutic Antibody, ADCC Enhanced
Anti-UPK1B ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies that specifically recognize and bind to UPK-Ib are useful in the diagnisic and/or treatment of cancer associated with abnormal expression of UPK-Ib. The disease state includes, but is not limited to, bladder cancer, transitional cell carcinoma of the bladder, ovarian cancer, Brenner ovarian cancer, lung cancer, and the like.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-629CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | UPK1B |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage |
|